En

The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

Mission

The Biological and Medicinal Chemistry Sector (BMCS) aims to further the interests of all members of the RSC, industrial and academic, involved in the pursuit and understanding of biologically active molecules. It also acts to promote public awareness of the crucial role played by chemistry in the modern industrial environment. 

Founded

1995 (Formerly Fine Chemicals & Medicinals Group)

Members

1500

Member profile

Academia + Industry

Postal address

Stuart Cameron
Concept Life Sciences, Peakdale Science Park
Sheffield Road
SK23 0PG Chapel-en-le-Frith United Kingdom

Phone number

+44 (1298) 816 700

Fax

+44 (1298) 816 701

Website

Activities

The BMCS is an interest group of the Royal Society of Chemistry (RSC) in the UK. The elected committee is primarily responsible for the organisation of Scientific Meetings and Symposia, supporting education and training in medicinal chemistry in the UK, and advising the RSC on policies that directly affect the BMCS. The predominant areas include pharmaceuticals and agrochemicals, and we also have strong links to chemical biology. The BMCS also acts to promote public awareness of the crucial role played by chemistry in the modern industrial environment.

The BMCS is particularly active in the organisation of scientific meetings and does so in collaboration with a wide variety of other learned societies both within and external to the RSC. We typically run several meetings each year jointly with the Society for Chemical Industry but we have also held or plan to hold internationally attended meetings with SEQT, the Swiss Chemical Society and PPINet. Any surplus from our meetings are reinvested to support educational activities at both primary and secondary school level, such as running lectures and day schools, and the provision of equipment.

The BMCS administers two biennial awards, the Malcolm Campbell Award and the Capps-Green-Zomaya Award, which acknowledge major scientific achievements in both academia and industry that have been carried out within the UK and Europe. In addition the BMCS supports medicinal chemistry at universities by funding a ‘BMCS Lectureship’ and travel bursaries for UK-based postgraduate students to allow attendance at international symposia. We have recently set up a ‘Medicinal Chemistry Hall of Fame’ which saw Sir Robin Ganellin as the first inductee – nominations for this are welcome at any time – and ‘Researcher Mobility Fellowships’ to further recognise and support our community.

  • 2nd Anglo-Swiss Symposium: Using Chemical Biology to identify new targets for Medicinal Chemistry
    (February 4, 2020), Basel, Switzerland
  • Applied Late-Stage Functionalisation: Where Chemistry Meets Biology
    (February 18-19, 2020), Cambridge, United Kingdom
  • 6th RSC / SCI Ion Channels as Therapeutic Targets Symposium
    (Febraury 24-25, 2020), Cambridge, United Kingdom
  • Synthesis in Drug Discovery and Development
    (March 27, 2020), Windlesham, United Kingdom
  • 2nd Nucleosides and Nucleotides: Synthetic and Biological Chemistry
    (April 21, 2020), London, United Kingdom
  • The 3rd SCI-RSC Symposium on Transporters in Drug Discovery and Development
    (April 21-22, 2020), London, United Kingdom
  • 31st Medicinal Chemistry in Eastern England
    (April 30, 2020), Hatfield, United Kingdom
  • 5th RSC / DMDG / DMG New Perspectives in DMPK
    (May 5-6, 2020), Liverpool, United Kingdom
  • 9th RSC / SCI Symposium on Kinase Inhibitor Design
    (June 1-2, 2020), London, United Kingdom
  • 6th RSC-BMCS Symposium on Mastering Medicinal Chemistry
    (June 12, 2020), Newcastle, United Kingdom
  • 3rd RSC / SCI / SEQT Symposium on Medicinal Chemistry for Global Health
    (June 24-26, 2020), Madrid, Spain
  • 8th RSC / SCI Symposium on GPCRs in Medicinal Chemistry
    (September 21-23, 2020), Verona, Italy

President

Dr WILLIAMS Andrew (Eli Lilly & Co. Ltd.)

Secretary

Dr CAMERON Stuart (Concept Life Sciences)

EFMC-Delegate

Dr ALKER David (David Alker Associates)